Lung Cancer

Therapy Areas

OncoNews

OncoNews

Lung Icon

Lung Cancer

Uterus Icon

Women's Cancers

Bladder Icon

Urogenital

GI Icon

Gastro-intestinal

Hematology Icon

Hematology

Other Solid Tumor Icon

Other Tumors

Highlighted OncoNews

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Videos

Lung Cancer by Solange Peters
Dec 17 2024
Lung Cancer

Lung Cancer 2024 REVIEW

} 1 h 43 min

watch now
Early NSCLC by Jean Yannis Perentes
Nov 26 2024
Lung Cancer

EARLY NSCLC

} 1 h 37 min

watch now
ADCs by Alessandra Curioni
Nov 06 2024
Antibody Drug Conjugates

Antibody Drug Conjugates

} 1 h 39 min

watch now
OncoViews on Lung Cancer by Alfredo Addeo
Jun 12 2024
Lung Cancer

Lung Cancer (ASCO 2024)

} 1 h 32 min

watch now
HER2 Session by Ilaria Colombo
Apr 30 2024
Biomarkers

HER2 in Lung, GYNE & GI Cancers

} 1 h 34 min

watch now
Biomarker Session by Sabina Berezowska
Feb 06 2024
Biomarkers

Biomarkers in GI & Lung

} 1 h 45 min

watch now
NSCLC Session by Isabelle Opitz
Jan 24 2024
Lung Cancer

Early NSCLC

} 1 h 30 min

watch now
Lung Cancer Session by Solange Peters
Dec 11 2023
Lung Cancer

Lung Cancer 2023 Review

} 1 h 34 min

watch now
ADC Session by Alfredo Addeo
Nov 01 2023
Antibody Drug Conjugates

ADC in Breast, GU & Lung

} 1 h 31 min

watch now
Lung Cancer Session by Alfredo Addeo
Jun 21 2023
Lung Cancer

Lung Cancer (ASCO 2023)

} 1 h 36 min

watch now

Articles

EMA Approval
Intravenous Drip
Feb 03 2025
Lung Cancer, Women's Cancers
CHMP Recommends Approval of Three Promising Therapies in the EU
Nuria María Novoa
Nuria Aaria Novoa
Jan 29 2025
Lung Cancer
Surgical Treatment of Lung Cancer: Defining Resectability in the Immunotherapy Era
PEAK Medicals
Jan 09 2025
Lung Cancer
Debate: Continuous Vs. Fixed-duration Immunotherapy
FDA Approval
Intravenous Drip
Dec 05 2024
Lung Cancer
FDA Approves New Therapies For NSCLC and SCLC
Swiss Approval
Blue Drug Capsules
Oct 11 2024
Lung Cancer
Swissmedic Approves Osimertinib for Locally Advanced EGFR-Positive NSCLC
EMA Approval
Intravenous Drip
Aug 30 2024
Lung Cancer, Urogenital
European Commission Approves New Treatments for Urothelial and Lung Cancer
PEAK Medicals
Lung X-Ray
Aug 01 2024
Lung Cancer
Celebrating Breakthroughs in Lung Cancer Treatment on World Lung Cancer Day
Swiss Approval
White drug capsules
Jul 26 2024
Lung Cancer
Swissmedic Approves Alectinib In Early Stage ALK+ NSCLC
Swiss Approval
CT Lung Image
Jul 04 2024
Lung Cancer
Swissmedic Approves Durvalumab for Perioperative Treatment of Resectable NSCLC
EMA Approval
Lung Cancer
Jun 10 2024
Lung Cancer
Alectinib Monotherapy Approved by the European Commission for ALK-Positive NSCLC

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

MPN

Gabriela Baerlocher

Hirslanden Clinic Zurich, Switzerland

Claire Harrison

Guy's and St. Thomas' NHS Foundation Trust, London, UK

Sara Meyer

Inselspital, University Hospital Bern, Switzerland

AGENDA

Managing PV and MF: Integrating interferons, immunotherapies and new JAK2 inhibitors

Sara Meyer

Clinical significance of genomic testing in MPN: When to test what and what does it really mean?

TBD

Update on the management of CML: Navigating through the available and upcoming treatment options

Gabriela Baerlocher

2 CME Points by

SWISS SOCIETY OF HEMATOLOGY
(SGH • SSH)

Join our host, Sara Meyer, for an insightful roundtable on the latest progress in the treatment of myeloproliferative neoplasms (MPNs). This interdisciplinary roundtable gathers renowned experts to discuss groundbreaking findings, offering an in-depth exploration of new innovative therapeutic approaches for myelofibrosis, polycythaemia vera and chronic myeloid leukemia. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the treatment landscape of myeloproliferative neoplasms.

ADD THIS TO YOUR CALENDAR

Register here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.

First Time On OncoViews?

Get Registered Now